Two‐tier subclassification of the Bethesda category III (atypia of undetermined significance/follicular lesion of undetermined significance) in thyroid cytology
Diagnostic Cytopathology · 2024
DOI: 10.1002/dc.25261 ↗At a glance
Journal article in Diagnostic Cytopathology, 2024. Written by Jay Alden and 2 co-authors. Institution: Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA. Major MEDLINE topics: Thyroid Neoplasms, Thyroid Nodule, Adenocarcinoma, Follicular. Cited 3 times so far (Crossref); 40 references.
Abstract (original language)
Background
The Bethesda category III, AUS/FLUS, comprises a heterogeneous group of thyroid lesions with variable risk of malignancy (ROM). This study evaluates ROM in two subgroups of this category based on nuclear atypia and architectural atypia.
Methods
Cases in Bethesda category III were reported based on nuclear atypia (AUS) and architectural atypia (FLUS). ROM was calculated by comparing the cytologic diagnosis to the follow‐up histologic diagnosis.
Results
Among the 610 Bethesda category III cases in this study, 306 (50.2%) and 304 (49.8%) cases were reported as AUS and FLUS, respectively. One hundred and eighty six of 306 AUS (60.8%) and 193 of 304 FLUS (63.5%) cases underwent surgical intervention. ROM of the cases in Bethesda category III was 12.8% if all cases were counted and 20.6% if only surgical cases were counted. When analyzing separately, ROM of AUS cases was 17.0% and 28.0% with all cases and surgical cases only, respectively. For FLUS cases, ROM was 8.6% and 13.5% with all cases and surgical cases only, respectively.
Conclusion
In Bethesda category III, ROM in the cases with nuclear atypia was significantly higher than the cases with architectural atypia. Sub‐classifying the Bethesda Category III cases with nuclear atypia and architectural atypia, respectively may better stratify the ROM.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
ORCID profiles: Jack Yang
Cite
APA
Alden, J., Lambrou, D., & Yang, J. (2024). Two‐tier subclassification of the Bethesda category III (atypia of undetermined significance/follicular lesion of undetermined significance) in thyroid cytology. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25261
Vancouver
Alden J, Lambrou D, Yang J. Two‐tier subclassification of the Bethesda category III (atypia of undetermined significance/follicular lesion of undetermined significance) in thyroid cytology. Diagnostic Cytopathology. 2024. doi:10.1002/dc.25261
BibTeX
@article{Alden2024,
author = {Alden, Jay and Lambrou, Denise and Yang, Jack},
title = {Two‐tier subclassification of the Bethesda category III (atypia of undetermined significance/follicular lesion of undetermined significance) in thyroid cytology},
journal = {Diagnostic Cytopathology},
year = {2024},
doi = {10.1002/dc.25261}
}
EUVIMED